Year |
Citation |
Score |
2023 |
Ruffenach G, Medzikovic L, Sun W, Hong J, Eghbali M. Functions of RNA-Binding Proteins in Cardiovascular Disease. Cells. 12. PMID 38132114 DOI: 10.3390/cells12242794 |
0.478 |
|
2023 |
Medzikovic L, Aryan L, Ruffenach G, Li M, Savalli N, Sun W, Sarji S, Hong J, Sharma S, Olcese R, Fishbein G, Eghbali M. Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblasts. Jci Insight. 8. PMID 37154157 DOI: 10.1172/jci.insight.168655 |
0.463 |
|
2022 |
Hong J, Wong B, Huynh C, Tang B, Ruffenach G, Li M, Umar S, Yang X, Eghbali M. Tm4sf1-marked Endothelial Subpopulation Is Dysregulated in Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. PMID 36252184 DOI: 10.1165/rcmb.2022-0020OC |
0.726 |
|
2022 |
Ruffenach G, Medzikovic L, Aryan L, Li M, Eghbali M. HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension. Circulation. 101161CIRCULATIONAHA. PMID 35993245 DOI: 10.1161/CIRCULATIONAHA.122.059591 |
0.55 |
|
2022 |
Cunningham CM, Li M, Ruffenach G, Doshi M, Aryan L, Hong J, Park J, Hrncir H, Medzikovic L, Umar S, Arnold AP, Eghbali M. Y-Chromosome Gene, , Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines. American Journal of Respiratory and Critical Care Medicine. PMID 35504005 DOI: 10.1164/rccm.202110-2309OC |
0.768 |
|
2022 |
Jayawardena E, Medzikovic L, Ruffenach G, Eghbali M. Role of miRNA-1 and miRNA-21 in Acute Myocardial Ischemia-Reperfusion Injury and Their Potential as Therapeutic Strategy. International Journal of Molecular Sciences. 23. PMID 35163436 DOI: 10.3390/ijms23031512 |
0.444 |
|
2020 |
Ruffenach G, Hong J, Vaillancourt M, Medzikovic L, Eghbali M. Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights. Respiratory Research. 21: 303. PMID 33208169 DOI: 10.1186/s12931-020-01570-2 |
0.575 |
|
2020 |
Hong J, Arneson D, Umar S, Ruffenach G, Cunningham CM, Ahn IS, Diamante G, Bhetraratana M, Park JF, Said E, Huynh C, Le T, Medzikovic L, Humbert M, Soubrier F, et al. Single-cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning. American Journal of Respiratory and Critical Care Medicine. PMID 33021809 DOI: 10.1164/rccm.202006-2169OC |
0.748 |
|
2020 |
Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. Journal of Molecular and Cellular Cardiology. PMID 32835666 DOI: 10.1016/J.Yjmcc.2020.08.007 |
0.524 |
|
2020 |
Ruffenach G, O'Connor E, Vaillancourt M, Hong J, Cao N, Sarji S, Moazeni S, Papesh J, Grijalva V, Cunningham CM, Shu L, Chattopadhyay A, Tiwari S, Mercier O, Perros F, et al. Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA12014. PMID 32713273 DOI: 10.1161/Hypertensionaha.120.14697 |
0.775 |
|
2020 |
Aryan L, Younessi D, Zargari M, Banerjee S, Agopian J, Rahman S, Borna R, Ruffenach G, Umar S, Eghbali M. The Role of Estrogen Receptors in Cardiovascular Disease. International Journal of Molecular Sciences. 21. PMID 32560398 DOI: 10.3390/Ijms21124314 |
0.725 |
|
2020 |
Umar S, Ruffenach G, Moazeni S, Vaillancourt M, Hong J, Cunningham C, Cao N, Navab S, Sarji S, Li M, Lee L, Fishbein G, Ardehali A, Navab M, Reddy ST, et al. Involvement of Low-Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension. Journal of the American Heart Association. 9: e012063. PMID 31914876 DOI: 10.1161/Jaha.119.012063 |
0.742 |
|
2020 |
Ruffenach G, Bonnet S, Rousseaux S, Khochbin S, Provencher S, Perros F. Identity crisis in pulmonary arterial hypertension. Pulmonary Circulation. 8: 2045893217746054. PMID 29206084 DOI: 10.1177/2045893217746054 |
0.438 |
|
2020 |
Cunningham CM, Umar S, Doshi M, Li M, Ruffenach G, Hrncir H, Arnold AP, Eghbali M. Y‐Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Lung Pro‐Inflammatory Cytokines The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02378 |
0.755 |
|
2019 |
Vaillancourt M, Chia P, Medzikovic L, Cao N, Ruffenach G, Younessi D, Umar S. Experimental Pulmonary Hypertension Is Associated With Neuroinflammation in the Spinal Cord. Frontiers in Physiology. 10: 1186. PMID 31616310 DOI: 10.3389/Fphys.2019.01186 |
0.708 |
|
2019 |
Ruffenach G, Umar S, Vaillancourt M, Hong J, Cao N, Sarji S, Moazeni S, Cunningham CM, Ardehali A, Reddy ST, Saggar R, Fishbein G, Eghbali M. Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis. Embo Molecular Medicine. e10061. PMID 31468711 DOI: 10.15252/Emmm.201810061 |
0.758 |
|
2019 |
Duhachek-Muggy S, Bhat K, Medina P, Cheng F, He L, Alli C, Saki M, Sree Muthukrishnan SD, Ruffenach G, Eghbali M, Vlashi E, Pajonk F. Radiation Mitigation of the Intestinal Acute Radiation Injury in Mice by 1-[(4-Nitrophenyl)Sulfonyl]-4-Phenylpiperazine. Stem Cells Translational Medicine. PMID 31464098 DOI: 10.1002/Sctm.19-0136 |
0.479 |
|
2019 |
Ruffenach G, Vaillancourt M, Hong J, Cao N, Cunningham C, Saggar R, Reddy S, Umar S, Fishbein G, Eghbali M. Abstract 494: Role of Slug / PIP Axis in Pulmonary Hypertension Secondary to Pulmonary Fibrosis Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.494 |
0.774 |
|
2019 |
Ruffenach G, O'Connor E, Vaillancourt M, Sarji S, Cao N, Aryan L, Cunningham C, Grijalva V, Umar S, Reddy S, Eghbali M, Moazeni D. Abstract 226: Apoai Mimetic Peptide 6f Prevent Pulmonary Hypertension Induced by Oxidized Lipids Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.226 |
0.743 |
|
2019 |
Oconnor EI, Ruffenach G, Grijalva V, Meriwether D, Papesh J, Dorreh N, Dorfman A, Eghbali M, Reddy S. Abstract 225: Evaluating Pro-Inflammatory and Pro-Resolving Lipid Modulations in an Oral 15-HETE Model of Pulmonary Hypertension Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.225 |
0.622 |
|
2018 |
F Tanguay V, Babin C, Giardetti G, Sohier-Poirier C, Ménard-Cholette V, Ranchoux B, Ruffenach G, Montani D, Bonnet S, Provencher S. Enhanced Pulmonary Artery Radiodensity in Pulmonary Arterial Hypertension: A Sign of Early Calcification? American Journal of Respiratory and Critical Care Medicine. PMID 30571924 DOI: 10.1164/Rccm.201806-1027Le |
0.513 |
|
2018 |
Iorga A, Umar S, Ruffenach G, Aryan L, Li J, Sharma S, Motayagheni N, Nadadur RD, Bopassa JC, Eghbali M. Estrogen rescues heart failure through estrogen receptor Beta activation. Biology of Sex Differences. 9: 48. PMID 30376877 DOI: 10.1186/S13293-018-0206-6 |
0.684 |
|
2018 |
Ruffenach G, O’Connor EI, Vaillancourt M, Sarji S, Cao N, Aryan L, Cunningham C, Grijalva V, Umar S, Reddy ST, Eghbali M. Abstract 250: Pulmonary Hypertension Induced by 15-HETE is Reverse by Apoai Mimetic Peptide 6f Administration Circulation Research. 123. DOI: 10.1161/Res.123.Suppl_1.250 |
0.742 |
|
2017 |
Vaillancourt M, Chia P, Sarji S, Nguyen J, Hoftman N, Ruffenach G, Eghbali M, Mahajan A, Umar S. Autonomic nervous system involvement in pulmonary arterial hypertension. Respiratory Research. 18: 201. PMID 29202826 DOI: 10.1186/S12931-017-0679-6 |
0.784 |
|
2017 |
Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biology of Sex Differences. 8: 33. PMID 29065927 DOI: 10.1186/S13293-017-0152-8 |
0.698 |
|
2017 |
Vaidya B, Pangallo M, Ruffenach G, Cunningham CM, Perron JC, Kolluru S, Eghbali M, Gupta V.. Advances in treatment of pulmonary arterial hypertension: patent review. Expert Opin Ther Pat.. 11: 1-12. PMID 28355094 DOI: 10.1080/13543776.2017.1313232. |
0.34 |
|
2017 |
Vaidya B, Pangallo M, Ruffenach G, Cunningham CM, Perron JC, Kolluru S, Eghbali M, Gupta V. Advances in treatment of pulmonary arterial hypertension: patent review. Expert Opinion On Therapeutic Patents. PMID 28355094 DOI: 10.1080/13543776.2017.1313232 |
0.622 |
|
2017 |
Umar S, Partow-Navid R, Ruffenach G, Iorga A, Moazeni S, Eghbali M. Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy. Biology of Sex Differences. 8: 9. PMID 28344760 DOI: 10.1186/S13293-017-0129-7 |
0.726 |
|
2016 |
Li J, Ruffenach G, Kararigas G, Cunningham CM, Motayagheni N, Barakai N, Umar S, Regitz-Zagrosek V, Eghbali M. Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway. Journal of Molecular and Cellular Cardiology. PMID 27847332 DOI: 10.1016/J.Yjmcc.2016.11.006 |
0.67 |
|
2016 |
Sharma S, Ruffenach G, Umar S, Motayagheni N, Reddy ST, Eghbali M. Role of oxidized lipids in pulmonary arterial hypertension. Pulmonary Circulation. 6: 261-73. PMID 27683603 DOI: 10.1086/687293 |
0.783 |
|
2016 |
Anwar A, Ruffenach G, Mahajan A, Eghbali M, Umar S. Novel biomarkers for pulmonary arterial hypertension. Respiratory Research. 17: 88. PMID 27439993 DOI: 10.1186/S12931-016-0396-6 |
0.771 |
|
2016 |
Ruffenach G, Chabot S, Tanguay VF, Courboulin A, Boucherat O, Potus F, Meloche J, Pflieger A, Breuils-Bonnet S, Nadeau V, Paradis R, Tremblay E, Girerd B, Hautefort A, Montani D, et al. Role for RUNX2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. PMID 27149112 DOI: 10.1164/Rccm.201512-2380Oc |
0.475 |
|
2016 |
Antigny F, Hautefort A, Meloche J, Belacel-Ouari M, Manoury B, Rucker-Martin C, Péchoux C, Potus F, Nadeau V, Tremblay E, Ruffenach G, Bourgeois A, Dorfmüller P, Breuils-Bonnet S, Fadel E, et al. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension. Circulation. 133: 1371-85. PMID 26912814 DOI: 10.1161/Circulationaha.115.020951 |
0.505 |
|
2016 |
Antigny F, Hautefort A, Meloche J, Belacel-Ouari M, Manoury B, Rucker-Martin C, Péchoux C, Potus F, Nadeau V, Tremblay E, Ruffenach G, Bourgeois A, Dorfmüller P, Breuils-Bonnet S, Fadel E, et al. Potassium-Channel Subfamily K-Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension Circulation. DOI: 10.1161/CIRCULATIONAHA.115.020951 |
0.331 |
|
2015 |
Meloche J, Potus F, Vaillancourt M, Bourgeois A, Johnson IH, Deschamps L, Chabot S, Ruffenach GN, Henry S, Breuils-Bonnet S, Tremblay È, Nadeau V, Lambert CM, Paradis R, Provencher S, et al. Bromodomain Containing Protein-4: The Epigenetic Origin of Pulmonary Arterial Hypertension. Circulation Research. PMID 26224795 DOI: 10.1161/Circresaha.115.307004 |
0.466 |
|
2015 |
Potus F, Ruffenach G, Dahou A, Thebault C, Breuils-Bonnet S, Tremblay È, Nadeau V, Paradis R, Graydon C, Wong R, Johnson I, Paulin R, Lajoie AC, Perron J, Charbonneau E, et al. Downregulation of miR-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation. PMID 26162916 DOI: 10.1161/Circulationaha.115.016382 |
0.463 |
|
2015 |
Vaillancourt M, Ruffenach G, Meloche J, Bonnet S. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension. The Canadian Journal of Cardiology. 31: 407-15. PMID 25630876 DOI: 10.1016/J.Cjca.2014.10.023 |
0.518 |
|
2014 |
Ruffenach G, Breuils-Bonnet S, Tremblay E, Provencher S, Bonnet S. IMPLICATION OF TRANSCRIPTIONAL FACTOR RUNX2 IN PULMONARY ARTERIAL HYPERTENSION Canadian Journal of Cardiology. 30: S124-S125. DOI: 10.1016/J.Cjca.2014.07.165 |
0.397 |
|
Show low-probability matches. |